- Home
- >
-
![When Surgery Alone Isn’t Enough: ALA-PDT Delivers a 23-Month Recurrence-Free Breakthrough for Periocular BCC]()
When Surgery Alone Isn’t Enough: ALA-PDT Delivers a 23-Month Recurrence-Free Breakthrough for Periocular BCC
This article presents three cases of periocular basal cell carcinoma (pBCC) treated with palliative surgery followed by ALA-PDT, achieving clinical cure with no recurrence over 12-23 months and excellent cosmetic outcomes. This combined approach offers a feasible option when complete surgical resection is challenging. -
![The Lancet Exclusive! Randomized Double-Blind Trial Results Reveal ALA-PDT as a Breakthrough Treatment for Recalcitrant Palmar and Plantar Warts]()
The Lancet Exclusive! Randomized Double-Blind Trial Results Reveal ALA-PDT as a Breakthrough Treatment for Recalcitrant Palmar and Plantar Warts
Groundbreaking Lancet study confirms ALA-PDT as a highly effective treatment for recalcitrant palmar and plantar warts, achieving 98%-100% clearance in six sessions with low recurrence rates. Learn more about this cutting-edge dermatological breakthrough.
Get the latest price? We'll respond as soon as possible(within 12 hours)